UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bone marrow failure and the telomeropathies

Blood, 2014-10, Vol.124 (18), p.2775-2783

2014

Volltextzugriff (PDF)

GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia

Blood, 2015-01, Vol.125 (1), p.56-70

2015

Volltextzugriff (PDF)

Single-cell RNA-seq reveals a distinct transcriptome signature of aneuploid hematopoietic cells

Blood, 2017-12, Vol.130 (25), p.2762-2773

2017

Volltextzugriff (PDF)

Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome

Haematologica (Roma), 2020-12, Vol.105 (12), p.2785-2794

2020

Volltextzugriff (PDF)

Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes

Haematologica (Roma), 2018-07, Vol.103 (7), p.1150-1159

2018

Volltextzugriff (PDF)

Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia

Blood, 2015-01, Vol.125 (4), p.706-709

2015

Volltextzugriff (PDF)

Acquired somatic mutations in PNH reveal long-term maintenance of adaptive NK cells independent of HSPCs

Blood, 2017-04, Vol.129 (14), p.1940-1946

2017

Volltextzugriff (PDF)

A plasma microRNA signature as a biomarker for acquired aplastic anemia

Haematologica (Roma), 2017-01, Vol.102 (1), p.69-78

2017

Volltextzugriff (PDF)

Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders

The European respiratory journal, 2017-01, Vol.49 (1), p.1601640-1601640

2017

Volltextzugriff (PDF)

Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia

Experimental hematology, 2018-02, Vol.58, p.39-43

2018

Volltextzugriff (PDF)

Identification of novel microRNA signatures linked to acquired aplastic anemia

Haematologica (Roma), 2015-12, Vol.100 (12), p.1534-1545

2015

Volltextzugriff (PDF)

In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia

Haematologica (Roma), 2014-09, Vol.99 (9), p.1433-1440

2014

Volltextzugriff (PDF)

Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes

International journal of hematology, 2013-07, Vol.98 (1), p.48-55

2013

Volltextzugriff (PDF)

Hematologic Complications of Pregnancy

Seminars in hematology, 2013-07, Vol.50 (3), p.222-231

Townsley, Danielle M

2013

Volltextzugriff (PDF)

Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia

The New England journal of medicine, 2017-04, Vol.376 (16), p.1540-1550

2017

Volltextzugriff (PDF)

Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes

British journal of haematology, 2017-04, Vol.177 (1), p.136-141

2017

Volltextzugriff (PDF)

Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing

Blood cells, molecules, & diseases, 2018-03, Vol.69, p.10-22

2018

Volltextzugriff (PDF)

Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ

Blood, 2019-05, Vol.133 (19), p.2043-2055

2019

Volltextzugriff (PDF)

Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms

Blood advances, 2018-01, Vol.2 (1), p.36-48

2018

Volltextzugriff (PDF)

Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug

Blood, 2014-03, Vol.123 (12), p.1818-1825

2014

Volltextzugriff (PDF)

Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Clinical cancer research, 2020-10, Vol.26 (20), p.5358-5367

2020

Volltextzugriff (PDF)

Immunosuppressive therapy in severe aplastic anemia

Seminars in hematology, 2022-01, Vol.59 (1), p.21-29

2022

Volltextzugriff (PDF)

Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study

The Lancet. Haematology, 2016, Vol.3 (1), p.e22-e29

2016

Volltextzugriff (PDF)

Eltrombopag added to immunosuppression for children with treatment‐naïve severe aplastic anaemia

British journal of haematology, 2021-02, Vol.192 (3), p.605-614

2021

Volltextzugriff (PDF)

The Spectrum of Hepatic Involvement in Patients With Telomere Disease

Hepatology (Baltimore, Md.), 2019-06, Vol.69 (6), p.2579-2585

2019

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(92)
Berichte
(1)

Sprache

Englisch
(93)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bone marrow failure and the telomeropathies

GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia

Single-cell RNA-seq reveals a distinct transcriptome signature of aneuploid hematopoietic cells

Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome

Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes

Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia

Acquired somatic mutations in PNH reveal long-term maintenance of adaptive NK cells independent of HSPCs

A plasma microRNA signature as a biomarker for acquired aplastic anemia

Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders

Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia

Identification of novel microRNA signatures linked to acquired aplastic anemia

In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia

Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes

Hematologic Complications of Pregnancy

Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia

Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes

Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing

Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ

Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms

Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug

Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors

Immunosuppressive therapy in severe aplastic anemia

Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study

Eltrombopag added to immunosuppression for children with treatment‐naïve severe aplastic anaemia

The Spectrum of Hepatic Involvement in Patients With Telomere Disease

Suchergebnisse filtern